Vaxxas – Needle-Free Vaccines
Vaccinations have historically been given using syringes and needles. Vaxxas is working on a new, less invasive vaccine delivery technology that creates a more potent immune response.
Vaxxas
Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.
The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.
Company Profile
Company: Vaxxas Pty Ltd
Sector: Biotechnology
Location: Brisbane
Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.
We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.